SUMMARY
# Microglial Aging and Immune Memory in Neurodegeneration — Training the Brain's Macrophages
## Background and Rationale
The human brain's resident immune cells, microglia, represent far more than passive sentinels of the central nervous system. These dynamic cells possess remarkable plasticity, capable of adopting distinct phenotypic states that profoundly influence neuronal health and disease progression. The concept of microglial "trained immunity" has emerged as a revolutionary paradigm in n
METHODOLOGY NOTES
**Phase 1: Human Tissue Collection and Processing (Weeks 1-4)**
• Collect postmortem brain tissue from n=60 donors (20 healthy controls, 20 early-stage AD, 20 advanced AD) matched for age (65-85 years)
• Isolate microglia from frontal cortex and hippocampus using CD11b+ magnetic bead separation
• Process fresh tissue within 4 hours of autopsy for viable cell isolation
• Cryopreserve aliquots in liquid nitrogen for molecular analysis
• Perform initial viability assessment using trypan blue exclusion (target >80% viability)
**Phase 2: Microglial Phenotyping and DAM Characterization (Weeks 5-8)**
• Conduct single-cell RNA sequencing on freshly isolated microglia (minimum 5,000 cells per sample)
• Analyze DAM signature genes: TREM2, ApoE, CD68, CLEC7A, TYROBP using qRT-PCR
• Perform flow cytometry for surface markers: CD11b, CD45, TMEM119, P2RY12
• Measure inflammatory cytokines (IL-1β, TNF-α, IL-6, IL-10) using multiplex ELISA
• Assess phagocytic capacity using fluorescent Aβ42 oligomers